DCM
MRNA icon

Davis Capital Management’s Moderna MRNA Stock Holding History

Davis Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630 Buy
9
+8
+800% +$414 ﹤0.01% 570
2026
Q1 		$51 Buy
+1
New +$47 ﹤0.01% 581

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Davis Capital Management's MRNA Position: Q2 2026 in Review

Davis Capital Management increased its Moderna (MRNA) stake by 800% in Q2 2026, buying an estimated $414 and bringing the position to 9 shares worth $630. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Davis Capital Management first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Davis Capital Management held 9 shares of Moderna worth $630 as of Q2 2026.
  • Davis Capital Management bought 8 Moderna shares in Q2 2026, an estimated $414.
  • Moderna made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #570 holding.
  • Davis Capital Management first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.